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Superoxide  anion  induces  pain  and inﬂammation.
Targeting  TNF/TNFR1  signaling  reduces  superoxide  anion-induced  pain/  inﬂammation.
TNF/TNFR1  signaling  mediates  superoxide  anion-induced  oxidative  stress.
Inhibiting  NADPH  oxidase  and SOD  mimicry  reduce  TNF-induced  pain  and  inﬂammation.
Superoxide  anion-induced  pain  and  inﬂammation  depends  on TNF/TNFR1  signaling.
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a  b  s  t  r  a  c  t
Inhibition  of tumor  necrosis  factor-alpha  (TNF)  and  superoxide  anion  production  reduces  inﬂammation
and  pain.  The  present  study  investigated  whether  superoxide  anion-induced  pain  depends  on  TNF  sig-
naling  and  the  role  of superoxide  anion  in TNF-induced  hyperalgesia  to clarify  the  interrelation  between
these  two mediators  in  the  context  of pain.  Intraplantar  injection  of  a superoxide  anion  donor  (potas-
sium  superoxide)  induced  mechanical  hyperalgesia  (0.5–5  h  after  injection),  neutrophil  recruitment
(myeloperoxidase  activity),  and  overt  pain-like  behaviors  (paw  ﬂinching,  paw  licking,  and  abdominal
writhings)  in  wild-type  mice.  Tumor  necrosis  factor  receptor  1 deﬁciency  (TNFR1-/-)  and  treatment  of
wild-type  mice  with  etanercept  (a soluble  TNFR2  receptor  that  inhibits  TNF actions)  inhibited  super-
oxide  anion-induced  pain-like  behaviors.  TNFR1−/− mice  were  also  protected  from  superoxide  anion
donor-induced  oxidative  stress,  suggesting  the  role  of this  pathway  in the  maintenance  of  oxidativeNF
NFR1
stress.  Finally,  we  demonstrated  that  Apocynin  (an  NADPH  oxidase  inhibitor)  or Tempol  (a  superoxide
dismutase  mimetic)  treatment  inhibited  TNF-induced  paw  mechanical  hyperalgesia  and  neutrophil
recruitment  (myeloperoxidase  activity).  These  results  demonstrate  that  TNF/TNFR1  signaling  is impor-
tant  in  superoxide  anion-triggered  pain  and  that  TNF/TNFR1  signaling  ampliﬁes  the  oxidative  stress
triggered  by superoxide  anion,  which  contributes  to sustaining  pain  and  inﬂammation.
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Targeting superoxide anion and tumor necrosis factor-alpha
(TNF) alleviate pain and inﬂammation [1,17,22]. Depending on
disease context model, TNF sensitizes nociceptive neurons acting
indirectly via prostaglandin E2 production and directly on nocicep-
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his sensitization results in hyperalgesia [13]. TNF also induces
nﬂammation, neutrophil recruitment and activates superoxide-
enerating systems, which contribute to increasing oxidative stress
nd pain [5,6,22]. Furthermore, superoxide anion also contributes
o pain and hyperalgesia [13,17]. In fact, superoxide anion up-
egulates TNFR1 expression in nociceptive neurons and increases
NF production [18,20]. It is not known, however, whether TNF
ignaling represents a crucial step in pain transmission and hyper-
lgesia induced by superoxide anion. In this study, we aimed to
escribe the role of TNF/TNFR1 during pain and inﬂammation
nduced in mice by a superoxide anion donor (potassium super-
xide). Additionally, we evaluated the reciprocal contribution of
uperoxide anion during mechanical hyperalgesia induced by TNF
njection.
. Materials and methods
.1. Animals
C57BL/6 wild-type (WT) control mice and C57BL/6 TNFR1−/−
ice were provided by University of São Paulo (São Paulo, Brazil).
ehavioral tests were performed between 9 a.m. and 5 p.m. in
 temperature-controlled room. Animal experiments and proce-
ures were conducted according to the International Association
or Study of Pain (IASP) guidelines and with approval (process
1.2012.68) by the Ethics Committee of Universidade Estadual de
ondrina.
.2. Drugs and reagents
Potassium superoxide (KO2) 96.5% was purchased from Alfa
esar (Ward Hill, MA,  USA). Phosphate buffered saline (PBS),
rtho-dianisidine dihydrochloride, 4-nitrophenyl N-acetyl--d-
lucosaminide, trichloroacetic acid (TCA), thiobarbituric acid (TBA),
itro blue tetrazolium (NBT), HTAB (Bromide, hexadecyltrimethy-
ammonium), dihydrochloride orto-dianisidine, glutathione (GSH),
DTA sodium salt, ferric chloride hexahydrate, TPTZ (2,4,6-
ripiridil-s-triazine), ABTS [2,2-azinobis (3-ethylbenzothiazoline-
-10 sulfonate), diammonium salt], Trolox (6-hydroxy-2,5,7,8-
etramethylchroman-2-11 carboxylic acid), PMSF (phenylmethane
ulfonyl ﬂuoride), Tempol, and Apocynin were purchased from
igma Chemical Co. (St. Louis, MO,  USA).
.3. Stimuli and treatments
KO2 stimulus was diluted in saline immediately before its use
nd administered by intraplantar (i.pl.) (30 g, 25 L) or intraperi-
oneal (i.p.) (1 mg,  100 L) injection [8]. TNF stimulus (100 ng,
5 L of saline) was administered by i.pl. injection. Etanercept (1,
 or 10 mg/kg, diluted in 100 L of saline) treatment was given by
.p. route 48 h and 1 h before KO2 stimulus. Apocynin (100 mg/kg,
.p., diluted in 100 L of DMSO 1% in saline) treatment was  adminis-
ered 30 min  before TNF stimulus. Tempol (100 mg/kg, i.p., diluted
n 100 L of saline) was administered 40 min  before TNF stimulus.
ilot studies based the doses of stimuli and treatment [17].
.4. Behavioral tests
The International Association for the Study of Pain (IASP) deﬁnes
yperalgesia as an increase of pain sensation caused by a stimulus
hat normally induces a nociceptive response. On the other hand,
llodynia is deﬁned as pain sensation caused by a stimulus that
ormally does not induce nociceptive response [21]. Mechanical
timuli elicit both hyperalgesia and allodynia in sensitized tissues.
he electronic von Frey is characterized by a basal response to
echanical stimulus, indicating mechanical hyperalgesia is undernce Letters 605 (2015) 53–58
evaluation differing from the classic von Frey ﬁlaments, which
does not elicit a basal response, therefore, evaluating allodynia.
Another difference between electronic von Frey and classic von
Frey ﬁlaments is that results are given in g and log, respectively
[8]. Mechanical hyperalgesia was  evaluated with a hand-held force
transducer (electronic anesthesiometer; Insight, Ribeirão Preto, SP,
Brazil) adapted with a 0.5 mm2 polypropylene tip between 0.5–5 h
after KO2 (30 g, 25 L) or TNF (100 ng, 25 L) i.pl. injection.
In this method, mice were placed in acrylic cages with wire grid
ﬂoors, 15 min  before testing. The investigator was trained to apply
the tip perpendicularly to the central area of the hind paw with
a gradual increase in pressure. The removal of the paw followed
by clear ﬂinching movement characterized the end point, and the
apparatus recorded the intensity of pressure automatically. Mice
were tested before (basal) and after treatment and stimuli, and the
value for each interval was  an average of three measurements. The
results are expressed by delta ()  withdrawal threshold (in g), cal-
culated by subtracting the mean measurements at the indicated
time points after stimulus from the basal mean measurements
[8,17]. The total number of paw ﬂinches and time spent licking the
paw were measured 0–30 min  after i.pl. stimulus with KO2 (30 g,
25 L). Abdominal writhings were measured 0–20 min  after i.p.
stimulus with KO2 (1 mg,  100 L). TNF was  not able to induce
overt pain-like behaviors (paw ﬂinches, paw licking, abdominal
writhings) [17].
2.5. Myeloperoxidase (MPO) activity
Neutrophil recruitment to plantar skin was  evaluated by MPO
activity kinetic colorimetric assay [2]. Mice were terminally anes-
thetized 5 h after stimulus injection. Plantar skin samples were
collected in 50 mM K2PO4 buffer (pH 6.0) containing 0.5% HTAB and
stored at −20 ◦C. MPO  activity was  determined at 450 nm (Multi-
skan GO Microplate Spectrophotometer, Thermo Scientiﬁc, Vantaa,
Finland). A standard curve of neutrophils was used. Results are
presented as the number of neutrophils (×104) per mg  of tissue.
2.6. TNF  ˛ levels
Plantar skin samples were collected 3 h after i.pl. stimulus with
KO2 (30 g, 25 L) and homogenized immediately in ice-cold PBS
buffer containing protease inhibitor (1 mM PMSF, Sigma–Aldrich).
TNF levels were determined at 450 nm (Multiskan GO,  Thermo
Scientiﬁc) by enzyme-linked immunosorbent assay (ELISA) using
eBioscience kits. Results are expressed as picograms (pg) of TNF
per mg  of tissue.
2.7. Superoxide production
Superoxide anion production was measured in plantar skin sam-
ples collected 3 h after i.pl. stimulus with KO2 (30 g, 25 L) by
the nitroblue tetrazolium (NBT) assay adapted to a microplate [18].
NBT reduction was measured at 600 nm (Multiskan GO,  Thermo
Scientiﬁc). Sample weighting was  used for data normalization.
2.8. Lipid peroxidation
The thiobarbituric acid reactive substances (TBARS) assay was
used to determine lipid peroxidation [1]. Plantar skin samples
were collected 3 h after i.pl. stimulus with KO2 (30 g, 25 L) and
homogenized immediately in ice-cold KCl buffer (500 L, 1.15%
w/v). Malondialdehyde (MDA) levels, an intermediate product of
lipid peroxidation, was determined in samples by the difference
between the absorbance at 535 and 572 nm (Multiskan GO, Thermo
Scientiﬁc). Results are presented as nmol of MDA  per mg  of tissue.
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Fig.1. Superoxide anion-induced mechanical hyperalgesia, neutrophil recruitment, and overt pain-like behaviors depend on TNFR1 activation. Mice received i.pl. injection
of  30 g (A–D) or i.p. injection of 1 mg  (E) of KO2 (superoxide anion donor). Mechanical hyperalgesia (A) was determined at 0.5, 1, 3 and 5 h after the stimulus. Paw skin
























oumber of writhing (E) was evaluated over 20 min. Results are expressed as mean ±
p  < 0.05 vs. saline group #p < 0.05 vs. KO2 group (two-way repeated measure ANOV
ost  hoc).
.9. ABTS and FRAP assays
The ability of samples to resist oxidative damage was  deter-
ined by its ABTS radical scavenging and ferric reducing (FRAP
ssay) properties. The tests were adapted to a 96-well microplate
ormat as previously described [1]. Plantar skin samples were
ollected 3 h after i.pl. stimulus with KO2 (30 g, 25 L) and homog-
nized immediately in ice-cold KCl buffer (500 L, 1.15% w/v).
he absorbance of ABTS and FRAP assays were measured at 730
nd 595 nm (Multiskan GO Thermo Scientiﬁc), respectively and
quated against a standard Trolox curve (0.02–20 nmol). Results
re expressed as nmol of Trolox equivalent per mg  of tissue.
.10. GSH levels
Antioxidant levels of plantar skin were evaluated by measuring
he levels of reduced glutathione (GSH), the most abundant non-
nzymatic antioxidant of cells. Samples of plantar skin tissue were
ollected 3 h after KO2 i.pl. stimulus (30 g, 25 L) and maintained
t −80 ◦C for 48 h. GSH levels were measured as described previ-
usly [19], and the absorbance was measured at 412 nm (Multiskan
O, Thermo Scientiﬁc). Results were equated against a standard
SH curve (0.02–20 nmol) and expressed as nmol of GSH per mg  of
lantar skin tissue..11. Statistical analysis
Results are presented as means ± SEM of measurements made
n 6 mice in each group per experiment, representative of 2 (n = 6 per group per experiment, representative of two independent experiments).
owed Tukey’s post hoc and for single time point One-way ANOVA followed Tukey’s
independent experiments. Two-way repeated measure analysis of
variance (ANOVA) followed by Tukey’s post hoc was used when
responses were measured at different times points after the stimu-
lus injection. One-way ANOVA followed by Tukey’s post hoc test was
performed to compare the values at the indicated time points. Sta-
tistical differences were considered to be signiﬁcant when P < 0.05.
3. Results
Superoxide anion-induced mechanical hyperalgesia, neutrophil
recruitment, and overt pain-like behaviors depend on TNFR1 acti-
vation
Firstly, the role of TNF in nociceptive neuron activation and
sensitization induced by superoxide anion was  investigated. For
this purpose, we stimulated wild-type (WT) and TNFR1−/− mice
with KO2 and compared their responses regarding mechanical
hyperalgesia, neutrophil recruitment, and overt pain-like behavior.
Superoxide anion induced mechanical hyperalgesia at all evaluated
intervals (0.5–5 h) in WT  mice, while TNFR1−/− mice exhibited a sig-
niﬁcant reduction in the intensity of this effect (Fig. 1A). Neutrophil
recruitment (MPO activity) to the plantar skin was  fully inhibited in
TNFR1−/− mice (Fig. 1B). TNFR1 deﬁciency also reduced superoxide
anion-induced overt pain-like behaviors of paw ﬂinching (Fig. 1C),
paw licking (Fig. 1D), and abdominal writhings (Fig. 1E).
TNF blockade by Etanercept treatment inhibits mechanical
hyperalgesia, neutrophil recruitment, and overt pain-like behaviors
induced by superoxide anion
The nociceptive and inﬂammatory responses induced by super-
oxide anion in WT  mice treated with Etanercept (1–10 mg/kg, i.p.,
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Fig. 2. TNF blockade by Etanercept treatment inhibits in a dose-dependent manner the mechanical hyperalgesia, neutrophil recruitment, and overt pain-like behaviors
induced  by superoxide anion. Mice were treated with etanercept (1, 3 or 10 mg/kg, i.p.) 1 h before i.pl. injection of 30 g (A–D) or i.p. injection of 1 mg (E) of KO2. Paw skin
samples  were collected at 5 h to determine the myeloperoxidase activity (B). The number of ﬂinches (C) and time spent licking (D) the paw were evaluated over 30 min.






























Herein, we provide evidence that superoxide anion also medi-
ates the hyperalgesia that is induced after TNF production. The
present ﬁndings suggest that superoxide anion can depolarizexperiments). *p < 0.05 vs. saline group #p < 0.05 vs. KO2 group (two-way repeated
ollowed Tukey’s post hoc).
8 h and 1 h before KO2 stimulus) were also tested. Etanercept is
 soluble TNFR2 receptor that is therapeutically used to reduce
he available TNF diminishing the activation of membrane TNF
eceptors and consequent pro-inﬂammatory actions [10]. Etan-
rcept treatment at the dose of 10 mg/kg reduced superoxide
nion-induced mechanical hyperalgesia at all evaluated intervals
Fig. 2A). The dose of 3 mg/kg of etanercept was able to inhibit
echanical hyperalgesia at 0.5 h only (Fig. 2A). The dose of 1 mg/kg
f etanercept did not alter superoxide anion-induced mechanical
yperalgesia (Fig. 2A). On the other hand, all three tested doses
f etanercept were able to inhibit superoxide anion-induced neu-
rophil recruitment (MPO activity) in the plantar skin, without
ifferences between the three doses (Fig. 2B). Ten mg/kg of etaner-
ept reduced superoxide anion-induced overt pain-like behaviors
f paw ﬂinching (Fig. 2C), paw licking (Fig. 2D), and abdominal
rithings (Fig. 2E).
Superoxide anion increases TNF production and induces oxida-
ive stress in a TNFR1-dependent manner
Plantar skin samples were collected 3 h after superoxide anion
timulus to measure TNF production and oxidative stress. We
ound an increase in TNF concentration (Fig. 3A) in plantar skin
amples 3 h after superoxide anion injection, suggesting the role
f this cytokine in the maintenance of mechanical hyperalgesia
nduced by superoxide anion. In line with this hypothesis, super-
xide anion injection triggered an up-regulation of endogenous
roduction of superoxide anion that was dependent on TNFR1
eceptor activity (Fig. 3B). Moreover, oxidative stress induced by
uperoxide anion injection was also dependent on TNFR1 activity
Fig. 3C–E).sure ANOVA followed Tukey’s post hoc and for single time point One-way ANOVA
TNF-induced mechanical hyperalgesia and MPO  activity
depend on enzymes that generate superoxide anion.
Next, we  investigated the role of endogenous superoxide anion
production in the mechanical hyperalgesia and neutrophil recruit-
ment (MPO activity) induced by TNF. TNF induced mechanical
hyperalgesia at all evaluated time points (0.5–5 h) after injection
(Fig. 4A), which was  inhibited in mice treated with an NADPH
inhibitor (Apocynin) or a superoxide dismutase mimetic (Tempol)
(Fig. 4A). Furthermore, Apocynin and Tempol were able to reduce
TNF-induced neutrophil recruitment (MPO activity) in the plantar
skin (Fig. 4B).
4. Discussion
The present study shows that superoxide anion-induced pain
and inﬂammation depend on TNF production and TNFR1 activa-
tion. This signaling generates a positive feedback loop: superoxide
anion induces TNF production that, in turn, triggers the endoge-
nous production of superoxide anion.
Superoxide anion and TNF seem to be key mediators of this
positive feedback loop as their inhibition was  effective in reduc-
ing mechanical hyperalgesia and neutrophil recruitment. In fact, it
has been demonstrated that superoxide anion represents a crucial
mediator during TNF processing into its active form [20,26].nociceptive neurons since it evoked overt pain-like behaviors.
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Fig. 3. Superoxide anion increases TNF production and induces oxidative stress in a TNFR1-dependent manner. Mice received i.pl. injection of 30 g KO2. Paw skin samples
were  collected 3 h after stimulus to determine TNF tissue concentration (A), superoxid
(ABTS assay) (D), ferric reducing antioxidant power (FRAP assay) (E) and GSH concentr
representative of two independent experiments). *p < 0.05 vs. saline group #p < 0.05 vs. K
Fig. 4. TNF-induced mechanical hyperalgesia and MPO  activity depend on super-
oxide anion. Mice were treated with Apocynin (100 mg/kg, i.p., 30 min) or Tempol
(100 mg/kg, i.p., 40 min) before i.pl. injection of 100 ng TNF. Mechanical hyperal-
gesia (A) was determined at 0.5, 1, 3 and 5 h after the stimulus. Paw skin samples
were collected at 5 h to determine myeloperoxidase (MPO) activity (B). Results are
expressed as mean ± SEM (n = 6 per group per experiment, representative of two














TNFR2 through enhanced expression of transient receptor poten-ay  repeated measure ANOVA followed Tukey’s post hoc and for single time point
ne-way ANOVA followed Tukey’s post hoc).
n turn, TNF plays a major role during neuronal sensitization,
hich is in line with previous works reporting that TNF mod-
lates the activity of sodium channels in nociceptive neurons
9,13]. Hence, we provided evidence that TNF and TNFR1 are
ecessary to induce superoxide anion-triggered overt pain-like
ehaviors of paw ﬂinching, paw licking, and abdominal writhings.
ndependent studies reported that reactive oxygen species and
NF increase the excitability of nociceptive neurons through a
38 mitogen-activated protein kinase modulation of sodium chan-
els activity [13,20,24,27–29]. However, the exact mechanisms by
hich superoxide anion uses TNF/TNFR1 pathway in neuronse anion production (NBT assay) (B), MDA  formation (C) total antioxidant capacity
ation (F). Results are expressed as mean ± SEM (n = 6 per group per experiment,
O2 group (one-way ANOVA followed Tukey’s post hoc).
to depolarize these cells is a topic that certainly deserves further
investigation.
In addition to TNFR1, TNFR2 receptors are likely participat-
ing in superoxide anion-induced pain and inﬂammation since the
treatment with etanercept induced a greater reduction of super-
oxide anion-induced mechanical hyperalgesia than the genetic
deﬁciency of TNFR1. Etanercept is a soluble TNFR2 receptor that
is therapeutically used to scavenge TNF, thus preventing TNF
binding to membrane TNFR1 and TNFR2 receptors and the conse-
quent cellular activation. The treatment with etanercept reduces
pain in models of inﬂammation [3], cancer [4] and neuropathy
[16]. TNFR2 and TNFR1 deﬁciency reduce inﬂammatory [7,14],
cancer [11] and neuropathic pain [31]. Acute treatment with
anti-TNFR1 and/or anti-TNFR2 antibodies also reduce nocicep-
tive responses [12,30]. On the other hand, TNFR1/TNFR2 double
deﬁciency enhanced pain sensitivity observed as bilateral orofa-
cial pain following infraorbital nerve ligation, and chronic pain
in arthritis induced by complete Freundı´s adjuvant injection in
the knee joint followed by gastrointestinal challenge with intra-
colonic mustard oil injection (double hit model). Furthermore,
TNFR1/TNFR2 double deﬁciency resulted in up-regulation of var-
ied pro-inﬂammatory and hyperalgesic cytokines and chemokines
[15,25]. In contrast, bone ﬁbrosarcoma-induced tactile hypersen-
sitivity was almost abolished in TNFR1/TNFR2 double deﬁcient
mice with reduced astrogliosis and increased spontaneous pain-
like behavior and tumor growth. Genetic deﬁciency of one of
TNF receptors did not affect bone cancer-induced tactile hyper-
sensitivity, spontaneous pain-like behavior, spinal astrogliosis
and tumor growth [11]. The injection of lung carcinoma cells
in the paw induces thermal hyperalgesia with a major role oftial vanilloid 1 (TRPV1) [4]. In chronic constriction injury-induced
neuropathic pain, TNFR1 deﬁciency reduced thermal hyperalge-















































necrosis factor receptor subtypes 1 and 2 in the red nucleus in the
development of neuropathic pain, Neurosci. Lett. (2014) 43–48, 21.
[31] L. Zhang, T. Berta, Z.Z. Xu, T. Liu, J.Y. Park, R.R. Ji, TNF- contributes to spinal8 F.Y. Yamacita-Borin et al. / Neu
llodynia [23]. Therefore, targeting TNFR1 and/or TNFR2 may
resent beneﬁcial and/or detrimental effects depending on disease
ontext.
. Conclusions
TNF/TNFR1 signaling contributes signiﬁcantly to superoxide
nion-induced inﬂammation and pain. There is a positive feed-
ack loop in which superoxide anion induces TNF production,
hich in turn induces superoxide anion-mediated inﬂammation
nd pain. This study contributes to understanding the inﬂamma-
ory and nociceptive interaction between superoxide anion and
NF suggesting that targeting TNF reduces inﬂammatory dis-
ases exhibiting superoxide anion-dependent mechanisms, and
ice-versa.
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